BIO-TECHNE Corp (TECH)
$72.36-$0.11 (-0.15%) Today
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 11 | 302,815 | |
| Option exercise | 34 | 292,286 | |
| Tax withholding / forfeiture | 10 | 100,880 | |
| Derivative transaction | 10 | 159,872 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
64 Form 4 filings on record, the earliest from Oct 28, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kim Kelderman - Officer | Tax withholding / forfeiture | Common Stock | 2,303 | $62.57 | $144K | |
 William Geist - Officer | Option exercise | Common Stock | 9,911 | $0.00 | - | |
| William Geist - Officer | Tax withholding / forfeiture | Common Stock | 4,520 | $62.57 | $283K | |
| William Geist - Officer | Option exercise | Restricted Stock Units | 9,911 | $0.00 | - | |
| Rupert Vessey - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Rupert Vessey - Director | Grant or award | Stock Options (Right to Buy) | 3,777 | $0.00 | - | |
| Julie L. Bushman - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Julie L. Bushman - Director | Grant or award | Stock Options (Right to Buy) | 3,777 | $0.00 | - | |
| Joseph D. Keegan - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Joseph D. Keegan - Director | Grant or award | Stock Options (Right to Buy) | 3,777 | $0.00 | - | |
| John L. Higgins - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| John L. Higgins - Director | Grant or award | Stock Options (Right to Buy) | 3,777 | $0.00 | - | |
| Alpna Seth - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Alpna Seth - Director | Grant or award | Stock Options (Right to Buy) | 3,777 | $0.00 | - | |
| Amy E. Herr - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Amy E. Herr - Director | Grant or award | Stock Option (Right to Buy) | 3,777 | $0.00 | - | |
 Robert V. Baumgartner - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Robert V. Baumgartner - Director | Grant or award | Stock Options (Right to Buy) | 3,777 | $0.00 | - | |
| Judith V. Klimovsky - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Judith V. Klimovsky - Director | Grant or award | Stock Option (Right to Buy) | 3,777 | $0.00 | - | |
| Robert V. Baumgartner - Director | Option exercise | Common Stock | 17,040 | $21.84 | $372K | |
| Robert V. Baumgartner - Director | Open-market sale | Common Stock | 17,040 | $56.21 | $958K | |
| Robert V. Baumgartner - Director | Option exercise | Stock Options (Right to Buy) | 17,040 | $0.00 | - | |
| Roeland Nusse - Director | Option exercise | Common Stock | 17,040 | $21.84 | $372K | |
| Roeland Nusse - Director | Open-market sale | Common Stock | 17,040 | $56.36 | $960K | |
| Roeland Nusse - Director | Option exercise | Stock Options (Right to Buy) | 17,040 | $0.00 | - | |
| William Geist - Officer | Option exercise | Common Stock | 2,623 | $0.00 | - | |
| William Geist - Officer | Tax withholding / forfeiture | Common Stock | 803 | $53.60 | $43K | |
| William Geist - Officer | Option exercise | Restricted Stock Units | 2,623 | $0.00 | - | |
| William Geist - Officer | Grant or award | Performance Restricted Stock Units | 19,355 | $0.00 | - | |
| William Geist - Officer | Grant or award | Restricted Stock Units | 9,678 | $0.00 | - | |
| William Geist - Officer | Grant or award | Stock Options (Right to Buy) | 24,758 | $0.00 | - | |
| Matthew McManus - Officer | Option exercise | Common Stock | 2,637 | $0.00 | - | |
| Matthew McManus - Officer | Tax withholding / forfeiture | Common Stock | 880 | $53.60 | $47K | |
| Matthew McManus - Officer | Option exercise | Restricted Stock Units | 2,637 | $0.00 | - | |
| Matthew McManus - Officer | Grant or award | Performance Restricted Stock Units | 19,243 | $0.00 | - | |
| Matthew McManus - Officer | Grant or award | Restricted Stock Units | 9,622 | $0.00 | - | |
| Matthew McManus - Officer | Grant or award | Stock Option (Right to Buy) | 24,614 | $0.00 | - | |
| Shane Bohnen - Officer | Option exercise | Common Stock | 1,718 | $0.00 | - | |
| Shane Bohnen - Officer | Tax withholding / forfeiture | Common Stock | 527 | $53.60 | $28K | |
| Shane Bohnen - Officer | Option exercise | Restricted Stock Units | 50 | $0.00 | - | |
| Shane Bohnen - Officer | Option exercise | Restricted Stock Units | 1,668 | $0.00 | - | |
| Shane Bohnen - Officer | Grant or award | Performance Restricted Stock Units | 13,992 | $0.00 | - | |
| Shane Bohnen - Officer | Grant or award | Restricted Stock Units | 6,996 | $0.00 | - | |
| Shane Bohnen - Officer | Grant or award | Stock Option (Right to Buy) | 17,897 | $0.00 | - | |
| Amy E. Herr - Director | Option exercise | Common Stock | 279 | $0.00 | - | |
| Amy E. Herr - Director | Tax withholding / forfeiture | Common Stock | 101 | $53.60 | $5K | |
| Amy E. Herr - Director | Option exercise | Restricted Stock Units | 119 | $0.00 | - | |
| Amy E. Herr - Director | Option exercise | Restricted Stock Units | 160 | $0.00 | - | |
| Amy E. Herr - Director | Grant or award | Restricted Stock Units | 932 | $0.00 | - | |
| Amy E. Herr - Director | Grant or award | Stock Option (Right to Buy) | 2,735 | $0.00 | - | |
| Kim Kelderman - Officer | Option exercise | Common Stock | 8,543 | $0.00 | - | |
| Kim Kelderman - Officer | Tax withholding / forfeiture | Common Stock | 4,305 | $53.60 | $231K | |
| Kim Kelderman - Officer | Option exercise | Restricted Stock Units | 8,543 | $0.00 | - | |
| Kim Kelderman - Officer | Grant or award | Performance Restricted Stock Units | 70,708 | $0.00 | - | |
| Kim Kelderman - Officer | Grant or award | Restricted Stock Units | 35,354 | $0.00 | - | |
| Kim Kelderman - Officer | Grant or award | Stock Options (Right to Buy) | 90,441 | $0.00 | - | |
| James Hippel - Officer | Option exercise | Common Stock | 4,010 | $0.00 | - | |
| James Hippel - Officer | Tax withholding / forfeiture | Common Stock | 1,926 | $53.60 | $103K | |
| James Hippel - Officer | Option exercise | Restricted Stock Units | 4,010 | $0.00 | - | |
| James Hippel - Officer | Grant or award | Performance Restricted Stock Units | 29,420 | $0.00 | - | |
| James Hippel - Officer | Grant or award | Restricted Stock Units | 14,710 | $0.00 | - | |
| James Hippel - Officer | Grant or award | Stock Options (Right to Buy) | 37,632 | $0.00 | - | |
| John L. Higgins - Director | Option exercise | Common Stock | 5,040 | $21.84 | $110K | |
| John L. Higgins - Director | Option exercise | Stock Option (Right to Buy) | 5,040 | $0.00 | - | |
| James Hippel - Officer | Option exercise | Common Stock | 168,620 | $44.33 | $7.47M | |
| James Hippel - Officer | Tax withholding / forfeiture | Common Stock | 147,431 | $58.55 | $8.63M | |
| James Hippel - Officer | Option exercise | Stock Options (Right to Buy) | 168,620 | $0.00 | - | |
| Kim Kelderman - Officer | Option exercise | Common Stock | 48,176 | $44.33 | $2.14M | |
| Kim Kelderman - Officer | Tax withholding / forfeiture | Common Stock | 43,649 | $53.12 | $2.32M | |
| Kim Kelderman - Officer | Option exercise | Stock Option (Right to Buy) | 48,176 | $0.00 | - | |
| Kim Kelderman - Officer | Option exercise | Common Stock | 36,132 | $44.33 | $1.60M | |
| Kim Kelderman - Officer | Tax withholding / forfeiture | Common Stock | 32,933 | $51.42 | $1.69M | |
| Kim Kelderman - Officer | Option exercise | Stock Option (Right to Buy) | 36,132 | $0.00 | - | |
| John L. Higgins - Director | Option exercise | Common Stock | 12,000 | $21.84 | $262K | |
| John L. Higgins - Director | Option exercise | Stock Options (Right to Buy) | 12,000 | $0.00 | - | |
| William Geist - Officer | Option exercise | Common Stock | 9,912 | $0.00 | - | |
| William Geist - Officer | Tax withholding / forfeiture | Common Stock | 3,270 | $75.31 | $246K | |
| William Geist - Officer | Option exercise | Restricted Stock Units | 9,912 | $0.00 | - | |
| James Hippel - Officer | Option exercise | Common Stock | 13,159 | $0.00 | - | |
| James Hippel - Officer | Tax withholding / forfeiture | Common Stock | 6,475 | $75.31 | $488K | |
| James Hippel - Officer | Option exercise | Restricted Stock Units | 13,159 | $0.00 | - | |
| James Hippel - Officer | Grant or award | Restricted Stock Units | 34,634 | $0.00 | - | |
| Kim Kelderman - Officer | Tax withholding / forfeiture | Common Stock | 2,430 | $75.31 | $183K | |
| Judith V. Klimovsky - Director | Grant or award | Common Stock | 1,462 | $0.00 | - | |
| Judith V. Klimovsky - Director | Grant or award | Stock Option (Right to Buy) | 3,511 | $0.00 | - | |
| Alpna Seth - Director | Grant or award | Common Stock | 1,462 | $0.00 | - | |
| Alpna Seth - Director | Grant or award | Stock Options (Right to Buy) | 3,511 | $0.00 | - | |
| Rupert Vessey - Director | Grant or award | Common Stock | 1,462 | $0.00 | - | |
| Rupert Vessey - Director | Grant or award | Stock Options (Right to Buy) | 3,511 | $0.00 | - | |
| John L. Higgins - Director | Grant or award | Common Stock | 1,462 | $0.00 | - | |
| John L. Higgins - Director | Grant or award | Stock Options (Right to Buy) | 3,511 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
BIO-TECHNE Corp (TECH) had 16 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for TECH runs to 64 Form 4 filings, the earliest from 2024-10-28. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of TECH were filed in the last 90 days.
No insider sales of TECH were filed in the last 90 days. 4 sales are on record for this company.
This page tracks TECH Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add TECH to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
